$180bn Pfizer moves into a league of its own

October 28, 2003

$180bn Pfizer moves into a league of its ownThe newly enlarged Pfizer has begun life bullishly with a 10% growth …

Companies pay $344m fraud settlement

October 28, 2003

GlaxoSmithKline and Bayer have agreed to pay $344 million to settle charges of defrauding the US Government healthcare system.The payout …

Health service to pilot US system to tackle admissions

October 28, 2003

Primary care trusts in England are to work with US healthcare provider Kaiser Permanente on new ways to reduce hospital …

Abbott looks to seize lion’s share of RA market with Humira

October 28, 2003

Abbott Laboratories has launched its new rheumatoid arthritis treatment Humira in Europe claiming its biggest ever product could eventually become …

Novartis’ Cox-II challenger suffers set back

October 28, 2003

Prexige, the new challenger to the established Cox-II drugs from Novartis has been dealt a serious blow after the FDA …

Hassan takes on Schering-Plough revival

October 28, 2003

Fred Hassan has outlined his plans to turn round the fortunes of struggling Schering-Plough after being installed as the company's …

Swiss franc undercuts Roche growth

October 28, 2003

Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …

Ageing atypical could help cut suicide levels

October 28, 2003

Novartis' atypical antipsychotic Clozaril could lead to a reduction in suicide rate among patients suffering from schizophrenia, according to a …

Patent system damaging research

October 28, 2003

The UK patent system is damaging scientific research and creating a old rush mentality according to the Royal Society.The current …

Outlook improving for GSK

October 28, 2003

Human genome sequence completed

October 28, 2003

The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …

GSK claims victory in US parallel import row

October 27, 2003

GlaxoSmithKline has claimed victory in its controversial bid to block parallel imports of its drugs from Canada into the US.The …

Swiss franc undercuts Roche growth

October 27, 2003

Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …

Patent system damaging research

October 27, 2003

The UK patent system is damaging scientific research and creating a "gold rush mentality", according to the Royal Society.The current …

Human genome sequence completed

October 27, 2003

The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …

Humira launch costs hit Abbott

October 27, 2003

Abbott Labs recorded a 6% drop in profits for the first quarter of 2003 following heavy spending on the launch …

New CHAI head quits

October 27, 2003

Set back for GSK in Augmentin court battle

October 27, 2003

GlaxoSmithKline has suffered a set back in its bid to see off early US generic competition for antibiotic Augmentin, one …

The Gateway to Local Adoption Series

Latest content